Highlights
• Gregory Glenn, Novavax’s president of research and development said that with a high level of SARS-CoV-2 transmission observed and expected to continue in the United Kingdom
• The US government had awarded $1.6 billion to Novavax to develop and fund the drug, which is administered by two intramuscular injections.
• the company is optimistic that pivotal Phase 3 clinical tria....
Tags : Novavax, COVID-19 vaccine, Donald Trump, US government, coronavirus, ,
comments (0)